HDAC6 plays a role in promoting autophagy in glioma cells as a mechanism to promote resistance to TMZ [9] and antitumor immunotherapy [4], and HDAC6 inhibitors were recently reported to disrupt the autophagic process at the primary cilia in other cancer types [42]. Here, HDAC6 is linked to cancer.